by Jordana Choucair | Mar 2, 2022 | Life Sciences
A group of 13 lawmakers called on the Pharmaceutical Research and Manufacturers of America (PhRMA) to account for the “troubling price increases for brand name drugs” in January. The group, led by Senators Elizabeth Warren and Amy Klobuchar, accused...
by Jordana Choucair | Mar 2, 2022 | Life Sciences
The National Institutes of Health ordered a major review of federal biosecurity policies for experiments involving potentially dangerous pathogens. The agency hopes to gather recommendations by the end of 2022 on where to draw the line on potentially risky research....
by Jordana Choucair | Mar 2, 2022 | Opioid/Substance Use Disorders
Supreme Court justices struggled to define a legal standard to parse out unusual medical practices from drug dealing as they considered the cases of two doctors who were convicted of unlawful drug distribution. The justices deliberated how to read a phrase in a...
by Jordana Choucair | Mar 2, 2022 | Payers
A Milliman study conducted on behalf of the Better Medicare Alliance found that all but one Medicare Advantage (MA) plans are offering supplemental benefits in 2022. The study also found a 38 percent increase in supplemental benefits for helping the chronically ill....
by Jordana Choucair | Mar 2, 2022 | Providers
A study led by the American Medical Association (AMA) revealed that nearly $1 billion in annual excess health care spending is due to turnover of primary care physicians. The analysis found $979 million in excess health spending annually comes from primary care...
Recent Comments